Browse > Article

A Correspondence between Aging-related Reduction of Neprilysin and Elevation of Aβ-42 or γ-Secretase Activity in Transgenic Mice Expressing NSE-controlled APPsw or Human Mutant Presenilin-2  

Lim Hwa-J. (College of Pharmacy, Ewha Womans University)
Kim Yong-K. (Division of Laboratory Animal Resources, Korea Food and Drug Administration, National Institute of Toxicological Research)
Sheen Yhun-Y. (College of Pharmacy, Ewha Womans University)
Publication Information
Biomolecules & Therapeutics / v.14, no.2, 2006 , pp. 106-109 More about this Journal
Abstract
Neprilysin (Nep) is known to be important to degrade $A{\beta}$ derived from amyloid precursor protein (APP) by cleavage with $\beta-and\;\gamma$-secretases. In order to determine whether a correspondence between $A{\beta}-42/{\gamma}-secretase$ activity and Nep levels exists in postnatal aging of transgenic mice expressing either neuron-specific enolase (NSE)-controlled human mutant presenilin-2 (hPS2m) or APPsw alone, the levels of Nep expression and $A{\beta}-42/{\gamma}-secretase$ activity were examined age of 5, 12, and 20 months, respectively. The levels of Nep expression in both types of transgenic brains were decreased relative to those of control mice in a aging-related manner, while the level of $A{\beta}-42/{\gamma}-secretase$ activity was reversibly increased. Thus, changes in $A{\beta}-42$ may all reflect variation in amounts of Nep enzyme.
Keywords
Alzheimer; neprilysin; amyloid; transgenic;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Iwata, N., Takaki, Y., Fukami, S., Tsubuki, S., and Saido, T. C. (2002). Region-specific reduction of A$\beta$-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J. Neurosci. Res. 70, 493-500   DOI   ScienceOn
2 Lu, B., Gerard, N. P., Kolakowski, L. F. Jr., Bozza, M., Zurakowski, D., Finco, O., Carroll, M. C., and Gerard, C. (1995). Neutral endopeptidase modulation of septic shock. J. Exp. Med. 181, 2271-2275   DOI
3 Tumer, A. J., Issac, R. E., and Coates, D. (2001). The neprilysin (NEP) family of zinc metalloendopeptidase genomics and function. Bioassays. 23, 261-269   DOI   ScienceOn
4 Hwang, D. Y., Chae, K. R., Kang, T. S., Hwang, J. H., Lim, C. H., Kang, H. K., Goo, J. S., Lee, M. R., Lim, H. J., Min, S. H., Cho, J. Y., Hong, J. T., Song, C. W., Paik, S. G., Cho, J. S., and Kim, Y. K. (2002). Alterations in behavior, amyloid $\beta$-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. FASEB J. 16, 805-813   DOI   ScienceOn
5 Akiyama, H., Kondo, H., Ikeda, K., Kato, M., and McGeer, P. L. (2001). Immunohistochemical localization of neprilysis in the human cerebral cortex: inverse association with vulnerability to amyloid $\beta$-protein (A$\beta$) deposition. Brain Res. 902, 277-281   DOI   ScienceOn
6 Yasojima, K., McGeer, E. G., and McGeer, P. L. (2001b). Relationship between $\beta$-amyloid peptide generating molecules and neprilysin in Alzheimer's disease and normal brain. Brain Res. 919, 115-121   DOI   ScienceOn
7 Apelt, J., Ach, K., and Schliebs, R. (2003). Aging-related downregulation of neprilysin, a putative $\beta$-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of $\beta$-amyloid plaques. Neuroscu. Lett. 339, 183-186   DOI   ScienceOn
8 Glabe, C. (2000). Does Alzheimer disease tilt the scales of amyloid degradation versus accumulation? Nat. med. 6, 133-134   DOI   ScienceOn
9 Hwang, D. Y., Cho, J. S., Lee, S. H., Chae, K. R., Lim, H. J., Min, S. H., Seo, S. J., Song, Y. S., Song, C. W., Paik, S. K., Sheen, Y. Y., and Kim, Y. K. (2004). Aberrant expressions of pathogenic phenptype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw. Exp. Neurol. 186, 20-3   DOI   ScienceOn
10 Gomez-Isla, T., Price, J. L., MaKeel, D. W., Morris, J. C., Growdon, J. H., and Hyman, B. T. (1996). Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16, 4491-4500   DOI
11 Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoli, E., Kawashima-Morishima, M., Lee, H. J., Hama, E., Sekine-Aizawa, Y., and Saido, T. C. (2000). Identification of the major A$\beta$-42 degrading catabolic pathway in brain parenchyma suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150   DOI   ScienceOn
12 Mohajeri, M., Wollmer, M. A., and Nitsch, R. M. (2002). A$\beta$-42induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo. J. Biol. Chem. 277, 35460-35465   DOI   ScienceOn
13 Lu, B., Gerard, N. P., Kolakowski, L. F. Jr., Finco, O., Carroll, M. C., and Gerard, M. C. (1996). Neutral endopeptidase modulates septic shock. Ann. N.Y. Acad. Sci. 780, 156-163   DOI   ScienceOn
14 Yasojima, K., Akiyama, H., McGeer, E. G., and McGeer, P. L. (2001a) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship in deficient degradation of $\beta$amyloid peptide. Neurosci. Lett. 297, 97-100   DOI   ScienceOn